# Cytiva and Pall Corporation invest $1.5B in life sciences manufacturing capacity

Cytiva and Pall Corporation, part of Danaher, are investing $1.5 billion over two years to expand manufacturing capacity for biotechnology products at 13 sites globally, including new sites in the US and UK, and plan to hire 2,000 full-time associates.

- Type: Investment
- Announced: 2021-07-27
- Where: US, UK, Austria, China, Asia-Pacific, Europe
- Value: $1.50B
- Jobs: 2,000
- Status: announced
- Products: chromatography resins, cell culture media, single-use technologies
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Pall Corporation](https://endata.com/companies/11324.md)
- [Cytiva](https://endata.com/companies/38294.md)
- [Danaher](https://endata.com/companies/16260.md) (investor)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/cytiva-and-pall-corporation-investing-1-5-billion-usd-over-two-years-to-meet-growing-demand-for-biotechnology-solutions-883942289.html), 2021-07-27: "Our customers tell us they need access to manufacturing agility, a robust global supply chain and more regional options."
- [newswire.ca](https://www.newswire.ca/news-releases/cytiva-and-pall-corporation-investing-1-5-billion-usd-over-two-years-to-meet-growing-demand-for-biotechnology-solutions-883942289.html), 2021-07-27: "Our customers tell us they need access to manufacturing agility, a robust global supply chain and more regional options."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.